Pfizer, Teva bid to take over Ratiopharm

01/19/2010 | Forbes

Pfizer and Teva Pharmaceutical Industries are racing to take over German generic-drug firm Ratiopharm, business newspaper Handelsblatt reported. The two companies did not comment on the bidding, which could value Ratiopharm at $4 billion to $4.3 billion.

View Full Article in:

Forbes